{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T10:31:31Z","timestamp":1724841091706},"reference-count":34,"publisher":"Pan African Medical Journal","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pan Afr Med J"],"DOI":"10.11604\/pamj.2024.47.181.34571","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T15:17:32Z","timestamp":1722525452000},"source":"Crossref","is-referenced-by-count":1,"title":["Factors associated with mortality among laboratory-diagnosed drug-resistant tuberculosis patients on treatment, KwaZulu-Natal Province, 2017-2019"],"prefix":"10.11604","volume":"47","author":[{"given":"Moshibudi Poncho","family":"Phafane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Ngozo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zanele","family":"Radebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Lutge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Ebonwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4870","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref1","article-title":"Global tuberculosis report 2020","author":"World Health Organization","year":"2020","unstructured":"1. World Health Organization, Global tuberculosis report 2020, 2020;Accessed 27 May 2020"},{"key":"ref2","article-title":"The end TB strategy 2015","author":"World Health Organization","unstructured":"2. World Health Organization, The end TB strategy 2015, Accessed 27 May 2021"},{"issue":"9728","key":"ref3","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(10)60410-2","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis","volume":"375","author":"Gandhi NR, Nunn P, Dheda K, Schaa HS, Zignol M, van Soolingen D","year":"2010","unstructured":"3. Gandhi NR, Nunn P, Dheda K, Schaa HS, Zignol M, van Soolingen D, Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis, The Lancet, 2010;375(9728):1830-184","journal-title":"The Lancet"},{"key":"ref4","first-page":"73 17","article-title":"Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment","author":"Ormerod LP","year":"2005","unstructured":"4. Ormerod LP, Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment, Br Med Bull, 2005;73 17-74 2","journal-title":"Br Med Bull"},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","first-page":"e27610","DOI":"10.1371\/journal.pone.0027610","article-title":"Factors Associated with Anti-Tuberculosis Medication Adverse Effects: A Case-Control Study in Lima, Peru","volume":"6","author":"Chung-Delgado K, Revilla-Montag A, Guillen-Bravo S, Velez-Segovia E, Soria-Montoya A, Nu\u00f1ez-Garbin A","year":"2011","unstructured":"5. Chung-Delgado K, Revilla-Montag A, Guillen-Bravo S, Velez-Segovia E, Soria-Montoya A, Nu\u00f1ez-Garbin A, Factors Associated with Anti-Tuberculosis Medication Adverse Effects: A Case-Control Study in Lima, Peru, PLoS ONE, 2011;6(11):e27610","journal-title":"PLoS ONE"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s15010-013-0572-2","article-title":"Treatment outcomes of multidrug-resistant tuberculosis patients in Gauteng, South Africa","volume":"42","author":"Marais E, Mlambo CK, Lewis JJ, Rastogi N, Zozio T, Grobusch MP","year":"2014","unstructured":"6. Marais E, Mlambo CK, Lewis JJ, Rastogi N, Zozio T, Grobusch MP, Treatment outcomes of multidrug-resistant tuberculosis patients in Gauteng, South Africa, Infection, 2014;42405-413","journal-title":"Infection"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(10)60492-8","article-title":"Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study","volume":"375","author":"Dheda K, Shean K, Zumla A, Badri M, Streicher EM, Page-Shipp L","year":"2010","unstructured":"7. Dheda K, Shean K, Zumla A, Badri M, Streicher EM, Page-Shipp L, Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study, The Lancet, 2010;3751798-807","journal-title":"The Lancet"},{"issue":"4","key":"ref8","first-page":"447","article-title":"The increasing burden of tuberculosis in rural South Africa-impact of the HIV epidemic","volume":"87","author":"Wilkinson D, Davies GR","year":"1997","unstructured":"8. Wilkinson D, Davies GR, The increasing burden of tuberculosis in rural South Africa-impact of the HIV epidemic, S Afr Med J, 1997;87(4):447-50","journal-title":"S Afr Med J"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/QAI.0000000000001110","article-title":"Implementation and Operational Research: Clinical Impact of the Xpert MTB\/RIF Assay in Patients With Multidrug-Resistant Tuberculosis","volume":"73","author":"Padayatchi N, Naidu N, Yende-Zuma N, O\u00b4Donnell MR, Naidoo K, Augustine S","year":"2016","unstructured":"9. Padayatchi N, Naidu N, Yende-Zuma N, O\u00b4Donnell MR, Naidoo K, Augustine S, Implementation and Operational Research: Clinical Impact of the Xpert MTB\/RIF Assay in Patients With Multidrug-Resistant Tuberculosis, JAIDS J Acquir Immune Defic Syndr, 2016;73(1):e1-e7","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12879-017-2230-2","article-title":"Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine","volume":"17","author":"Aibana O, Bachmaha M, Krasiuk V, Rybak N, Flanigan TP, Petrenko V","year":"2017","unstructured":"10. Aibana O, Bachmaha M, Krasiuk V, Rybak N, Flanigan TP, Petrenko V, Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine, BMC Infect Dis, 2017;17(1):129","journal-title":"BMC Infect Dis"},{"issue":"9547","key":"ref11","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","article-title":"Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa","volume":"368","author":"Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U","year":"2006","unstructured":"11. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa, Lancet, 2006;368(9547):1575-80","journal-title":"Lancet"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1164\/rccm.200907-0989OC","article-title":"HIV coinfection in multidrug-and extensively drug-resistant tuberculosis results in high early mortality","volume":"181","author":"Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M","year":"2010","unstructured":"12. Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M, HIV coinfection in multidrug-and extensively drug-resistant tuberculosis results in high early mortality, Am J Respir Crit Care Med, 2010;181(1):80-86","journal-title":"Am J Respir Crit Care Med"},{"key":"ref13","article-title":"TB Statistics South Africa","author":"Annabel Kanabus","year":"2021","unstructured":"13. Annabel Kanabus, TB Statistics South Africa, 2021;Accessed 26 May 2021"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1183\/09031936.00155708","article-title":"Predictors of poor treatment outcome in multi-and extensively drug-resistant pulmonary TB","volume":"33","author":"Kliiman K, Altraja A","year":"2009","unstructured":"14. Kliiman K, Altraja A, Predictors of poor treatment outcome in multi-and extensively drug-resistant pulmonary TB, European Respiratory Journal, 2009;331085-1094","journal-title":"European Respiratory Journal"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"e0202469","DOI":"10.1371\/journal.pone.0202469","article-title":"Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013","volume":"13","author":"Chingonzoh R, Manesen MR, Madlavu MJ, Sopiseka N, Nokwe M, Emwerem M, Musekiwa A, Kuonza LR","year":"2018","unstructured":"15. Chingonzoh R, Manesen MR, Madlavu MJ, Sopiseka N, Nokwe M, Emwerem M, Musekiwa A, Kuonza LR, Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013, PLoS One, 2018;13(8):e0202469","journal-title":"PLoS One"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"e0225165","DOI":"10.1371\/journal.pone.0225165","article-title":"Determinants of mortality among patients with drug-resistant tuberculosis in northern Nigeria","volume":"14","author":"Bajehson M, Musa BM, Gidado M, Nsa B, Sani U, Habibu AT","year":"2019","unstructured":"16. Bajehson M, Musa BM, Gidado M, Nsa B, Sani U, Habibu AT, Determinants of mortality among patients with drug-resistant tuberculosis in northern Nigeria, PLOS ONE, 2019;14(11):e0225165","journal-title":"PLOS ONE"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"e0250804","DOI":"10.1371\/journal.pone.0250804","article-title":"Predictors of mortality and loss to follow-up among drug resistant tuberculosis patients in Oromia Hospitals, Ethiopia: A retrospective follow-up study","volume":"16","author":"Woldeyohannes D, Tekalegn Y, Sahiledengle B, Assefa T, Aman R, Hailemariam Z, Mwanri L, Girma A","year":"2021","unstructured":"17. Woldeyohannes D, Tekalegn Y, Sahiledengle B, Assefa T, Aman R, Hailemariam Z, Mwanri L, Girma A, Predictors of mortality and loss to follow-up among drug resistant tuberculosis patients in Oromia Hospitals, Ethiopia: A retrospective follow-up study, PLoS One, 2021;16(5):e0250804","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijid.2015.09.002","article-title":"Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort analysis of the national case register","volume":"39","author":"Schnippel K, Shearer K, Evans D, Berhanu R, Dlamini S, Ndjeka N","year":"2015","unstructured":"18. Schnippel K, Shearer K, Evans D, Berhanu R, Dlamini S, Ndjeka N, Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort analysis of the national case register, Int J Infect Dis, 2015;3989-94","journal-title":"Int J Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13690-020-00448-5","article-title":"Risk factors for mortality among drug-resistant tuberculosis patients registered for drug-resistant treatment in Amhara region, Ethiopia: a historical cohort study","volume":"78","author":"Ketema DB, Alene M, Assemie MA, Yismaw L, Merid MW","year":"2020","unstructured":"19. Ketema DB, Alene M, Assemie MA, Yismaw L, Merid MW, Risk factors for mortality among drug-resistant tuberculosis patients registered for drug-resistant treatment in Amhara region, Ethiopia: a historical cohort study, Arch Public Health, 2020;7869","journal-title":"Arch Public Health"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7196\/SAMJ.7689","article-title":"Tuberculosis control in South Africa: successes, challenges and recommendations","volume":"104","author":"Churchyard GJ, Mametja LD, Mvusi L, Ndjeka N, Hesseling AC, Reid A, Babatunde S, Pillay Y","year":"2014","unstructured":"20. Churchyard GJ, Mametja LD, Mvusi L, Ndjeka N, Hesseling AC, Reid A, Babatunde S, Pillay Y, Tuberculosis control in South Africa: successes, challenges and recommendations, S Afr Med J, 2014;104(3 Suppl 1):244-8","journal-title":"S Afr Med J"},{"issue":"6","key":"ref21","doi-asserted-by":"publisher","first-page":"e0253848","DOI":"10.1371\/journal.pone.0253848","article-title":"Predictors of mortality in patients with drug-resistant tuberculosis: A systematic review and meta-analysis","volume":"16","author":"Alemu A, Bitew ZW, Worku T, Gamtesa DF, Alebel A","year":"2021","unstructured":"21. Alemu A, Bitew ZW, Worku T, Gamtesa DF, Alebel A, Predictors of mortality in patients with drug-resistant tuberculosis: A systematic review and meta-analysis, PLoS One, 2021;16(6):e0253848","journal-title":"PLoS One"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.5588\/pha.14.0029","article-title":"Factors affecting treatment outcomes in drug-resistant tuberculosis cases in the Northern Cape, South Africa","volume":"4","author":"Elliott E, Draper HR, Baitsiwe P, Claassens MM","year":"2014","unstructured":"22. Elliott E, Draper HR, Baitsiwe P, Claassens MM, Factors affecting treatment outcomes in drug-resistant tuberculosis cases in the Northern Cape, South Africa, Public Health Action, 2014;4(3):201-3","journal-title":"Public Health Action"},{"key":"ref23","first-page":"6232071","article-title":"Factors Associated with Mortality among Patients on TB Treatment in the Southern Region of Zimbabwe 2013","volume":"2017","author":"Takarinda KC, Sandy C, Masuka N, Hazangwe P, Choto RC, Mutasa-Apollo T, Nkomo B, Sibanda E, Mugurungi O, Harries AD, Siziba N","year":"2017","unstructured":"23. Takarinda KC, Sandy C, Masuka N, Hazangwe P, Choto RC, Mutasa-Apollo T, Nkomo B, Sibanda E, Mugurungi O, Harries AD, Siziba N, Factors Associated with Mortality among Patients on TB Treatment in the Southern Region of Zimbabwe 2013, Tuberc Res Treat, 2017;20176232071","journal-title":"Tuberc Res Treat"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"e0144249","DOI":"10.1371\/journal.pone.0144249","article-title":"Tuberculosis Case Fatality and Other Causes of Death among Multidrug-Resistant Tuberculosis Patients in a High HIV Prevalence Setting, 2000-2008, South Africa","volume":"11","author":"van der Walt M, Lancaster J, Shean K","year":"2016","unstructured":"24. van der Walt M, Lancaster J, Shean K, Tuberculosis Case Fatality and Other Causes of Death among Multidrug-Resistant Tuberculosis Patients in a High HIV Prevalence Setting, 2000-2008, South Africa, PLoS One, 2016;11(3):e0144249","journal-title":"PLoS One"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5588\/ijtld.11.0153","article-title":"Risk factors for mortality among MDR-and XDR-TB patients in a high HIV prevalence setting","volume":"16","author":"Gandhi NR, Andrews JR, Brust JCM, Montreuil R, Weissman D, Heo M","year":"2012","unstructured":"25. Gandhi NR, Andrews JR, Brust JCM, Montreuil R, Weissman D, Heo M, Risk factors for mortality among MDR-and XDR-TB patients in a high HIV prevalence setting, Int J Tuberc Lung Dis, 2012;16(1):90-97","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"ref26","first-page":"849","article-title":"Mortality associated with tuberculosis\/HIV co-infection among patients on TB treatment in the Limpopo province, South Africa","volume":"14","author":"Mabunda TE, Ramalivhana NJ, Dambisya YM","year":"2014","unstructured":"26. Mabunda TE, Ramalivhana NJ, Dambisya YM, Mortality associated with tuberculosis\/HIV co-infection among patients on TB treatment in the Limpopo province, South Africa, Afr Health Sci, 2014;14(4):849-54","journal-title":"Afr Health Sci"},{"issue":"9","key":"ref27","first-page":"780","article-title":"Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000","volume":"6","author":"Santha T, Garg R, Frieden T. R, Chandrasekaran V, Subramani R, Gopi PG","year":"2002","unstructured":"27. Santha T, Garg R, Frieden T. R, Chandrasekaran V, Subramani R, Gopi PG, Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000, Int J Tuberc Lung Dis, 2002;6(9):780-788","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"ref28","first-page":"52","article-title":"Factors associated with mortality in tuberculosis patients","volume":"18","author":"Alavi-Naini R, Moghtaderi A, Metanat M, Mohammadi M, Zabetian M","year":"2013","unstructured":"28. Alavi-Naini R, Moghtaderi A, Metanat M, Mohammadi M, Zabetian M, Factors associated with mortality in tuberculosis patients, J Res Med Sci Off J Isfahan Univ Med Sci, 2013;18(1):52-55","journal-title":"J Res Med Sci Off J Isfahan Univ Med Sci"},{"key":"ref29","article-title":"Your personal research assistant","author":"Zotero","unstructured":"29. Zotero , Your personal research assistant, Accessed 20 January 2022"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/cid\/ciz914","article-title":"Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the United States","volume":"71","author":"Mase S, Chorba T, Parks S, Belanger A, Dworkin F, Seaworth B","year":"2020","unstructured":"30. Mase S, Chorba T, Parks S, Belanger A, Dworkin F, Seaworth B, Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the United States, Clin Infect Dis Off Publ Infect Dis Soc Am, 2020;71(4):1010-1016","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"2","key":"ref31","first-page":"e20210384","article-title":"Bedaquiline-containing regimens and multidrug-resistant tuberculosis: a systematic review and meta-analysis","volume":"48","author":"Hatami H, Abadi SSD, Migliori GB","year":"2022","unstructured":"31. Hatami H, Abadi SSD, Migliori GB, Bedaquiline-containing regimens and multidrug-resistant tuberculosis: a systematic review and meta-analysis, J Bras Pneumol J Bras Pneumol, 2022;48(2):e20210384","journal-title":"J Bras Pneumol J Bras Pneumol"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1186\/s12879-016-1997-x","article-title":"Predictors of hospitalization of tuberculosis patients in Montreal, Canada: a retrospective cohort study","volume":"16","author":"Ronald LA, FitzGerald JM, Benedetti A, Boivin J-F, Schwartzman K, Bartlett-Esquilant G","year":"2016","unstructured":"32. Ronald LA, FitzGerald JM, Benedetti A, Boivin J-F, Schwartzman K, Bartlett-Esquilant G, Predictors of hospitalization of tuberculosis patients in Montreal, Canada: a retrospective cohort study, BMC Infect Dis, 2016;16(1):679","journal-title":"BMC Infect Dis"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12890-018-0628-2","article-title":"Delays to treatment initiation is associated with tuberculosis treatment outcomes among patients on directly observed treatment short course in Southwest Ethiopia: a follow-up study","volume":"18","author":"Asres A, Jerene D, Deressa W","year":"2018","unstructured":"33. Asres A, Jerene D, Deressa W, Delays to treatment initiation is associated with tuberculosis treatment outcomes among patients on directly observed treatment short course in Southwest Ethiopia: a follow-up study, BMC Pulm Med, 2018;18(1):64","journal-title":"BMC Pulm Med"},{"issue":"2","key":"ref34","first-page":"163","article-title":"Community-based care vs. centralised hospitalisation for MDR-TB patients KwaZulu-Natal, South Africa","volume":"19","author":"Loveday M, Wallengren K, Brust J, Roberts J, Voce A, Margot B","year":"2015","unstructured":"34. Loveday M, Wallengren K, Brust J, Roberts J, Voce A, Margot B, Community-based care vs. centralised hospitalisation for MDR-TB patients KwaZulu-Natal, South Africa, Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis, 2015;19(2):163-171","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"}],"container-title":["The Pan African Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.panafrican-med-journal.com\/\/content\/article\/47\/181\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T15:18:03Z","timestamp":1722525483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.panafrican-med-journal.com\/\/content\/article\/47\/181\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":34,"URL":"https:\/\/doi.org\/10.11604\/pamj.2024.47.181.34571","relation":{},"ISSN":["1937-8688"],"issn-type":[{"value":"1937-8688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}